Ocular Therapeutix, Inc.

OCULNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
6.50 USD
↘ 0.11 (1.66%)AT CLOSE (03:59 PM EDT)
6.73
↗ 0.23 (3.46%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
6.73
↗ 0.23 (3.46%)
🔴Market: CLOSED

OCUL is currently priced at $6.50. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place OCUL at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$6.68
High?$6.68
Low?$6.35
Prev. Close?$6.61
Volume?1.9M
Avg. Volume?3.6M
VWAP?$6.45
Rel. Volume?0.51x
Bid / Ask
Bid?$6.39 × 100
Ask?$7.06 × 100
Spread?$0.67
Midpoint?$6.73
Valuation & Ratios
Market Cap?1.4B
Shares Out?219.6M
Float?190.6M
Float %?86.8%
P/E Ratio?N/A
P/B Ratio?2.74
EPS?-$1.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsMedical Devices & HealthTech›Wearable Medical Devices
Employees
325
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ocutx.com
Listed
2014-07-25
Address
14 CROSBY DRIVE, 3RD FLOOR
BEDFORD, MA 01730
Phone: 781-357-4000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
54
Momentum?
65
Short Sent.?
25
Piotroski F-Score?3/9Weak
Altman Z-Score?2.50Grey
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.43%High
Short Interest?29.4M
Days to Cover?7.3
Free Float190.6M
Avg Daily Volume4.1M
Settlement Date2026-09-30
Financial Health
Current Ratio?13.11Strong
Quick Ratio?13.03Strong
Cash Ratio?12.17Strong
Debt/Equity?0.14Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.74CHEAP▾
P/S?
Peers
100
S&P
3
27.42HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
17.32HIGH▾
Returns & Efficiency
ROE?
S&P
3
-58.0%WEAK▾
ROA?
S&P
3
-44.9%WEAK▾
Cash Flow & Enterprise
FCF?$-255100000
Enterprise Value?$901.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist